Cargando…
The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy
The current standard regimens for the treatment of acute myeloid leukemia (AML) are curative in less than half of patients; therefore, there is a great need for innovative new approaches to this problem. One approach is to target new treatments to the pathways that are instrumental to cell growth an...
Autores principales: | Gocek, Elzbieta, Studzinski, George P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470153/ https://www.ncbi.nlm.nih.gov/pubmed/26239344 http://dx.doi.org/10.3390/jcm4040504 |
Ejemplares similares
-
Differentiation Therapy of Acute Myeloid Leukemia
por: Gocek, Elzbieta, et al.
Publicado: (2011) -
Regulation of Leukemic Cell Differentiation through the Vitamin D Receptor at the Levels of Intracellular Signal Transduction, Gene Transcription, and Protein Trafficking and Stability
por: Gocek, Elżbieta, et al.
Publicado: (2012) -
NADPH-Cytochrome P450 Reductase Is Regulated by All-Trans Retinoic Acid and by 1,25-Dihydroxyvitamin D(3) in Human Acute Myeloid Leukemia Cells
por: Gocek, Elżbieta, et al.
Publicado: (2014) -
Differentiation and Cell Survival of Myeloid Leukemia Cells
por: Studzinski, George P., et al.
Publicado: (2012) -
Vitamin D Derivatives in Acute Myeloid Leukemia: The Matter of Selecting the Right Targets
por: Marcinkowska, Ewa
Publicado: (2022)